Skip to content
Research Article Open access CC BY 4.0

The Lipid Profile of Human Immunodeficiency Virus-infected Patients Receiving Antiretroviral Therapy at Mpilo Central Hospital Opportunistic Infections Clinic

N. Maunga, E. Zumbika, K. Mhandire, F. F. Chikuse, G. A. Mavondo

Advances in Research · pp. 1–10 · Published 29 Aug 2019

10.9734/air/2019/v20i130146

Abstract

Aims: Long term use of antiretroviral therapy subpopulation living with human immunodeficiency virus is associated with disturbances in blood lipids profiles which are not routinely monitored. More data on such disturbances are needed to persuade the country’s program to institute routine monitoring. This study sought to determine the prevalence and timing of dyslipidaemia in HIV/AIDS naïve people on ART at in Zimbabwe. Place and Duration of Study: The study was conducted at Mpilo Central Hospital Opportunistic Infections Clinic in Bulawayo, Zimbabwe over a period of three months. Methods: A cross-sectional study was conducted in HIV-infected persons receiving highly active anti-retroviral treatment at Mpilo Central Hospital Opportunistic Infections Clinic. Lipid assays were determined by Elisa methods. Viral loads and CD4 were measured using the COBAS® TaqMan® and BD FACSCount™ Flow Cytometer, respectively. Results: A total of 149 consenting participants were enrolled and most (63.2%) were females. The median age of the respondents was 43 years and their median CD4 count was 436 cells/μl after a median duration on ART of 36 months. Viral load was <40 in the majority (68.6%) of the participants. More females (63.1%) were on HAART and were aged >35 (60.4%) years. NNRTI (90.6%) were the more commonly prescribed HAART. The prevalence of dyslipidaemia was 70.2%. Hypercholesterolaemia was observed in 72 (48.3%) patients with 26 being male and 46 being female. High levels of LDL-cholesterol (LDL-c ≥ 3.0 mmol/L) were found in 115 patients with 74 of them being female. Hypertriacylglycerolaemia (TAG ≥ 2.0 mmol/L) was present in 8 cases. The proportion of patients with a low HDL-cholesterol (HDL-c < 1.0 mmol/L) was 15.3% while those with a ratio of TC/HDL-c ≥ 4.1 were 87.5%. Conclusion: The study demonstrated a high prevalence of dyslipidaemia in HIV-patients receiving HAART. There is a need for the Country’s HIV program to institute laboratory monitoring of blood lipids in patients over one year on HAART.

Dyslipidaemia high active antiretroviral therapy human immunodeficiency virus/ acquired immunodeficiency syndrome hypercholesterolaemia hypertriacylglycerolaemia.

References (17)

  1. 1 Mortality in the Highly Active Antiretroviral Therapy Era [DOI]
  2. 2 SREBP in signal transduction: cholesterol metabolism and beyond [DOI]
  3. 3 Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy [DOI]
  4. 4 HIV and HAART-Associated Dyslipidemia [DOI]
  5. 5 HIV Protease Inhibitor Induces Fatty Acid and Sterol Biosynthesis in Liver and Adipose Tissues Due to the Accumulation of Activated Sterol Regulatory Element-binding Proteins in the Nucleus [DOI]
  6. 6 Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy [DOI]
  7. 7 The metabolic effects of lopinavir/ritonavir in HIV-negative men [DOI]
  8. 8 Association of Serum Lipid Levels With HIV Serostatus, Specific Antiretroviral Agents, and Treatment Regimens [DOI]
  9. 9 Dyslipidemia related to antiretroviral therapy.
  10. 10 The lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian population [DOI]
  11. 11 Managing dyslipidemia in HIV/AIDS patients: challenges and solutions [DOI]
  12. 12 Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy [DOI]
  13. 13 Influence of protease inhibitor therapy on lipoprotein metabolism [DOI]
  14. 14 Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution [DOI]
  15. 15 Dyslipidemia in HIV-infected individuals [DOI]
  16. 16 Lipid Profile of Anti-Retroviral Treatment-Naοve HIV-Infected Patients in Jos, Nigeria [DOI]
  17. 17 Sex differences in HAART-associated dyslipidaemia [DOI]

Cited by 2

Nutritional status and effect of highly active anti-retroviral therapy (HAART) on selected trace elements in people living with HIV in Ghana

Regina Saka, Emmanuel A. Domfeh, Frank E. A Hayford · Scientific African · 2023

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

65

Page views

0

PDF downloads

10

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.